Abstract.
Recurrent reflex (or neurocardiogenic) syncope is a common clinical problem. Pacemaker therapy has been advocated as a potential therapy in severe or drug refractory cases of reflex syncope, while others have suggested that it may provide a benefit if employed as a primary therapeutic modality. The following paper reviews the concepts behind pacemaker therapy for reflex syncope and the results of various clinical trials that have evaluated its potential utility as a primary therapeutic modality.
Similar content being viewed by others
References
Grubb BP (1998) Neurocardiogenic syncope. In: Grubb BP, Olshansky B (eds) Syncope:Mechanisms and Management. Armonk, NY. Futura Publishing, pp 73–76
Kenny RA, Ingram A, Bayless T, Sutton R (1989) Head up tilt: A useful test for investigating unexplained syncope. Lancet 1:1352–1355
Grubb BP (1999) Pathophysiology and differential diagnosis of neurocardiogenic syncope. Am J Cardiol 84:3Q–9Q
Fitzpatrick A, Sutton R (1989) Tilting toward a diagnosis in recurrent unexplained syncope. Lancet, pp 658–660
Grubb B, Kosinski D (2001) Neurocardiogenic syncope: When and how to treat? ACC Curr J Rev 10(2):67
El-Badawi CY, Wahbra M, Hansworth R (1994) Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res 4:233–237
Benditt D, Ferguson D, Grubb BP, et al. (1996) Tilt table testing for assessing syncope. J Am Coll Cardiol 28:263–275
Sutton R, Petersen M, Brignole M, Raviele A, Venozzi C, Giani P (1992) Proposed classification for tilt induced syncope. Eur J Cardiac Electrophysiol 3:180
Benditt D, Peterson M, Lurie K, Grubb BP, Sutton R (1995) Cardiac pacing for prevention of recurrent vasovagal syncope. Am Intern Med 122:204–209
Krahn AD, Klein CJ, Norris C, Yee R (1996) The high cost of syncope: Use of a new insertable loop recorder in recurrent syncope of unknown etiology. Eur Heart J 17:3140
Sheldon R (1999) Role of pacing in the treatment of vasovagal syncope. Am J Cardiol 84:260–320
Fitzpatrick A, Theodorakis G, Ahmed R (1991) Dual chamber pacing aborts vasovagal syncope induced by head up 60° tilt. Pacing Clin Electrophysiol 14:13–19
Samoil D, Grubb BP, Brewster P, Moore J, Temesy-Armos P (1993) Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced syncope. Eur J Cardiac Electrophysiol 1:36
Sra JS, Jazayeri MR, Avital B, et al. (1993) Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic syncope with bradycardia or asystole. N Engl J Med 328:1085–1090
Petersen M, Chamberlain-Weber R, Fitzpatrick A, Ingram A, Williams J, Sutton R (1994) Permanent pacing for cardioinhibitory malignant vasovagal syncope. Br Heart J 71:274
Benditt D, Sutton R, Cummage M, Fertes J, Markowitz T (1997) Clinical experience with Thera DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pace 20:832
Ammirati F, Colivicchi F, Toscanos J, Pandozi C, Laudadio M, Seta F, Santini M (1998) DDI pacing with rate drop response versus DDR pacing with rate hysteresis for cardioinhibitory vagal syncope. PACE 21:2178
Sheldon RS, Kushman M, Wilson W, Kieger T, Rose S (1998) Effect of dual chamber pacing with automatic rate drop sensing on recurrent neurally mediated syncope. Am J Cardiol 81:158
Shah C, Thakur R, Xie B, Pathak P (1999) Dual chamber pacing for neurally mediated syncope with a prominent cardioinhibitory component. Pace 22:999–1003
Sutton R (2002) How and when to pace in vasovagal syncope. J Cardiovascular Electrophysiol 13(Suppl):514–516
Conolly S, Sheldon R, Roberts R, Gent M, et al. (1999) The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20
Sutton R, Brignole M, Menozzi C, Raviele Aboni P, Giani P, Moya A, et al. (2000) Dual chamber pacing in the treatment of neurally mediated tilt positive cardioinhibitory syncope. Pacemaker versus no therapy: A multicenter trial (VASIS Study). Circulation 102:294–299
McLeod K, Wilson N, Hewitt J, Stephenson J (1999) Double blind trial of cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizure. (Abstr) Pace 22:807
Ammirati F, Colivicchi F, Santini M (2001) Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. A multicenter randomized control trial. Circulation 104:52–57
Connolly SJ, Sheldon R, Thorpe KE, et al. (2003) Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA 289:2224–2229
Gregoratos G, et al. (2002) ACC/AHA/NASPE 2002 guideline for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 106:2145–2161
Grubb BP, Wolfe D, Samoil D, et al. (1993) Adaptive rate pacing controlled by right ventricular pre-ejection interval for severe refractory orthostatic hypotension. PACE 16:801–805
Grubb BP (1998) New Concepts in Sensor Technology. In: Barold S, Mutigea J (eds) New Perspectives in Cardiac Pacing. Futura Publishing, Armonk,NY, pp 888–100
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kosinski, D.J., Grubb, B.P. & Wolfe, D.A. Permanent cardiac pacing as primary therapy for neurocardiogenic (reflex) syncope. Clin Auton Res 14 (Suppl 1), i76–i79 (2004). https://doi.org/10.1007/s10286-004-1011-3
Issue Date:
DOI: https://doi.org/10.1007/s10286-004-1011-3